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Abstract In order to examine the primary structure of
acetoacetyl-CoA synthetase (acetoacetate-CoA ligase, EC
6.2.1.16; AA-CoA synthetase), the cDNA clone encoding this
enzyme has been isolated from the cDNA library which was
prepared from the liver of rat fed a diet supplemented with 4%
cholestyramine and 0.4% pravastatin for 4 days. Nucleotide
sequence analysis of cloned cDNA revealed that AA-CoA
synthetase of rat liver contains an open reading frame of 2019
nucleotides, and the deduced amino acid sequence (672 amino
acid residues) bears 25.0 and 38.9% homologies with acetyl-CoA
synthetases of Saccharomyces cerevisiae and Archaeoglobus
fulgidus, respectively.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Acetoacetyl-CoA synthetase (acetoacetate-CoA ligase, EC
6.2.1.16; AA-CoA synthetase) is a novel cytosolic acetoace-
tate-activating enzyme puri¢ed for the ¢rst time from Zoo-
gloea ramigera I-16-M, a bacterium isolated from activated
sludge [1] and rat liver [2] by us. Although cytosolic activation
of acetoacetate to its CoA ester was ¢rst observed in pigeon
liver homogenate by Stern and Ochoa [3] in 1951, the enzyme
responsible for this reaction had not been identi¢ed until we
puri¢ed AA-CoA synthetase as a discrete acetoacetate-speci¢c
ligase.
In mammals, AA-CoA synthetase is present in the cytosolic
fractions of various tissues [4^7], especially lipogenic ones,
and acetoacetate is known to be e¡ectively incorporated
into cholesterol and fatty acids [8]. These results indicate
that AA-CoA synthetase may supply acetyl units to cytosolic
compartment for cholesterol and/or fatty acid biosynthesis.
Furthermore, the activity [4] and content [5] of AA-CoA syn-
thetase is enhanced in rat liver by the administration of hypo-
cholesterolemic agents, such as cholestyramine and ML-236B
(compactin), suggesting that this enzyme is involved in choles-
terol biosynthesis. However, the physiological role of AA-
CoA synthetase is not fully understood. To clarify the func-
tion of AA-CoA synthetase in mammalian cells and to con-
¢rm discreteness of the enzyme, it is essential to isolate the
cDNA clones for this protein. In this study we report the
cloning of cDNA encoding AA-CoA synthetase from the
cDNA library obtained from the liver of rat fed a diet sup-
plemented with pravastatin and cholestyramine.
2. Materials and methods
2.1. Dietary experiment
Female rats of the Sprague-Dawley (SD) strain (6 weeks old, 130^
150 g) were from Tokyo Laboratory Animals Science Co., Ltd. (To-
kyo, Japan). They were fed a standard diet (Mouse Flat, Oriental
Yeast Co., Ltd., Japan) supplemented with 0.4% pravastatin and
4% cholestyramine, which were kindly donated by Sankyo Co. Ltd.
(Tokyo, Japan) and Bristol-Myers Squibb K.K. (Tokyo, Japan), re-
spectively.
2.2. Enzyme assay and determination of enzyme protein concentration
AA-CoA synthetase activity was assayed as described previously
[2]. AA-CoA synthetase protein concentration was estimated by en-
zyme immunoassay using anti-rat AA-CoA synthetase antiserum of
rabbit [5] as described previously [9].
2.3. Protein digestion and separation of peptides
Puri¢ed enzyme [2] was lyophilized and dialyzed against the bu¡ers
suitable for each of the following peptidases. The enzyme was digested
with lysyl endopeptidase (Wako Pure Chemical Industries, Ltd., Osa-
ka, Japan), chymotrypsin (Wako), or trypsin (Sigma, St. Louis, MO,
USA) under the optimum condition as described in the manufac-
turers’ instructions. The resulting peptides were separated by a W
blotter system (PE Applied Biosystems, Foster City, CA, USA) using
a linear gradient of 0^80% acetonitrile containing 0.1% tri£uoroacetic
acid with a £ow rate of 5 Wl/min. Absorbance was monitored at 210
nm.
2.4. Amino acid sequencing
Peptide fragments were sequenced by the automated Edman degra-
dation using an amino acid sequencer Procise cLC (PE Applied Bio-
systems).
2.5. cDNA library construction
The several preliminary trials to obtain cDNA clones for AA-CoA
synthetase from the liver of the rat fed a normal diet were unsuccess-
ful possibly because the content of AA-CoA synthetase mRNA in the
liver was very low. Therefore, total RNA was obtained by the acid
guanidinium-phenol-chloroform method [10] from liver of female SD
rat fed a diet supplemented with 0.4% pravastatin plus 4% cholestyr-
amine for 4 days (see Section 3). Poly(A) RNA was separated from
the total RNA using Oligotex(dT)30-Super (Takara Shuzo Co. Ltd.,
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Japan), and cDNA library was constructed from poly(A) RNA ac-
cording to the method of Gluber and Ho¡man [11] using the vector
VZipLox (GIBCO BRL, Grand Island, NY, USA).
2.6. 3P-RACE method
Rapid ampli¢cation of cDNA ends (RACE) [12] was done using a
Takara 3P-Full RACE Core Set (Takara Shuzo). First-strand cDNA
was synthesized using oligo dT-3 sites adaptor primer and 1 Wg of
total RNA as a template. Second-strand cDNA was synthesized using
the oligonucleotide (5P-CTCGGATCCCTCAAYGGCAAGAAAGT-
GGA-3P, 29-mer), where Y is C or T. The 20-mer of this 29-mer
oligonucleotide was derived from the sequences of EST clones
R48370 (human) and W12611 (mouse) (see Section 3) and the se-
quence of BamHI restriction site, and three extra nucleotides were
added to its 5P-end. The ampli¢ed DNA by PCR was digested with
BamHI, and inserted to the BamHI site of the pUC118 plasmid.
2.7. DNA sequencing
The sequencing reaction was performed by dideoxynucleotide chain
termination method using a Bigdye terminator cycle sequencing FS
ready reaction kit (PE Applied Biosystems). The reaction mixture was
analyzed with a 377 automated DNA sequencer (PE Applied Biosys-
tems). The deleted clones for sequencing of the entire region of the
cDNA were prepared using a Kilo sequence deletion kit (Takara
Shuzo).
3. Results and discussion
3.1. Induction of rat liver AA-CoA synthetase
Since this enzyme is known to be induced by hypocholes-
terolemic agent [4,5], we investigated the e¡ect of administra-
tion of pravastatin, a new potent 3-hydroxy-3-methylglutaryl-
CoA inhibitor clinically used in the treatment of hypercholes-
terolemia [13], as well as of cholestyramine, an accelerator of
bile acid excretion, on the AA-CoA content in rat liver. As
shown in Fig. 1, the enzyme content in the liver extract in-
creased about 5.0-, 8.4-, and 9.3-fold on days 2, 4, and 7,
respectively, of the start of feeding rats with the diet contain-
ing both 4% cholestyramine and 0.4% pravastatin. Thus,
cDNA library was constructed using puri¢ed mRNAs isolated
from livers of rat fed a diet supplemented with 0.4% pravas-
tatin plus 4% cholestyramine for 4 days (see Section 2).
3.2. 3P-RACE
The puri¢ed AA-CoA synthetase was digested with lysyl
endopeptidase, chymotrypsin or trypsin, and the peptide frag-
ments obtained were separated. Table 1 shows the eight di¡er-
ent amino acid sequences determined by the automated Ed-
man degradation method. EST database was surveyed for the
sequence of the peptide 8 (TVEHRGAFSNPESLDLYRDI-
PELQD) (Table 1). Four EST clones were obtained, which
were (1) R48370 yj67e08.r1 Homo sapiens cDNA clone 153830
5P, (2) R59020 yg96d03.r1 H. sapiens cDNA clone 41440 5P,
(3) N71593 yw38c12.r1 H. sapiens cDNA clone 254518 5P, and
(4) W12611 ma71b12.r1 Soares mouse p3NMF19.5 Mus mus-
culus cDNA clone 316127 5P. The oligonucleotide (5P-CTCG-
GATCCCTCAAYGGCAAGAAAGTGGA-3P, 29-mer) was
designed from the nucleotide sequences of EST clones (1)
R48370 (human) and (4) W12611 (mouse), and used for syn-
thesizing second-strand of cDNA in the 3P-RACE method.
Thus, a cDNA fragment of 1.2 kb length was obtained, and
it was con¢rmed to contain a partial open reading frame,
termination codon and 3P-non-coding region of the cDNA.
The sequence of peptide 8 (Table 1) was present in the amino
acid sequence deduced from the cDNA sequence.
3.3. cDNA for AA-CoA synthetase
From the nucleotide sequence of the 1.2 kb cDNA frag-
ment, two synthetic antisense oligonucleotides, 5P-CTTGGA-
TCCACCGAGTGCGAGCCATTGGT-3P and 5P-CTTGGA-
TCCGCTGTCCCTAAGTTCCATCA-3P, which were derived
from the region after termination codon (TGA) of the 1.2 kb
cDNA fragment, were designed. From the nucleotide se-
quence of the vector VZipLox, two oligonucleotides, 5P-CTT-
GGATCCCACACAGGAAACAGCTATGA-3P and 5P-CT-
TGGATCCCCATGATTACGCCAAGCTCT-3P, were also
designed. The speci¢c cDNA fragments ampli¢ed on the
whole cDNA library with these four oligonucleotides were
Table 1
Codon and nucleotide location of peptide fragments of AA-CoA synthetase determined by protein microsequencing
Peptide fragment Amino acid sequence Codon location Nucleotide location
Peptide 1 IADVPEWF 87^94 367^390
Peptide 2 VVLIPYV 236^242 814^834
Peptide 3 FLDDFLASGT 258^267 880^909
Peptide 4 VDRIGITI 370^377 1216^1239
Peptide 5 GIVMLGR 533^539 1705^1725
Peptide 6 NIVEAFDEVE 558^567 1780^1809
Peptide 7 VVLFLK 583^588 1855^1872
Peptide 8a TVEHRGAFSNPESLDLYRDIPELQD 647^671 2047^2121
Amino acids are listed by their single letter designation, with their amino acid position (codon location) and nucleotide location on the AA-
CoA synthetase cDNA.
aPeptide sequence used for library screening.
Fig. 1. Time course of the induction of AA-CoA synthetase by hy-
pocholesterolemic agents. Female rats (6 weeks old) were fed with
the standard diet (a), or with the standard diet containing 0.4%
pravastatin (O), 4% cholestyramine (E), or 0.4% pravastatin and
4% cholestyramine (7). (A) AA-CoA synthetase activity and (B)
AA-CoA synthetase protein content in the liver supernatant fraction
were measured as described in Section 2. Each point represents the
mean þ S.E. of three experiments.
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digested with BamHI, inserted to the BamHI site of pUC118,
and transferred to Escherichia coli JM109. Thirteen clones
encoding the open reading frame of AA-CoA synthetase
were obtained, and two of them contained the initiation co-
don. Fig. 2a shows the restriction map of the entire cDNA
clone. Although the N-terminal amino acid sequence of the
puri¢ed AA-CoA synthetase has not been clari¢ed so far be-
cause of N-terminal blocking of the enzyme, the ATG codon
at nucleotide 109 in the translation frame was tentatively con-
cluded to be the initiator codon since the Kozak’s consensus
sequence for initiation of translation in vertebrates [14] was
conserved at nucleotides 101 to 111. These clones had a cod-
ing region for a protein of 672 amino acid residues with a
calculated molecular weight of 75 039 Da (Fig. 2b). All pep-
tide sequences (Table 1) analyzed using the puri¢ed AA-CoA
synthetase were seen in the deduced amino acid sequence of
this protein (Fig. 2b).
Since the molecular weight of 71 000 Da estimated by SDS^
Fig. 2. Structure of the cDNA. (a) Restriction map of the cDNA. The solid box represents the open reading frame. (b) Nucleotide sequences
and amino acid sequences of AA-CoA synthetase. The amino acid sequences determined by protein microsequencing (Table 1) and putative
poly(A) addition signal are underlined.
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PAGE [2] is smaller than the calculated molecular weight, it is
possible that the translated protein is truncated by post-tran-
scriptional modi¢cation. Previous studies showed that alter-
native translation initiation generated isoforms of acyl-CoA
synthetase 3 [15]. We saw four in-frame ATG codons from
nucleotides 109 to 195, and supposed that the forth ATG was
initiator. Then the calculated molecular weight would be
71 645 Da, which is in good agreement with that estimated
by SDS^PAGE. The possibility of the presence of alternative
translation or post-transcriptional modi¢cation requires fur-
ther investigation.
3.4. Homology
The amino acid sequence deduced from the open reading
frame was searched in protein sequence database [16]. The
amino acid sequence of rat liver AA-CoA synthetase showed
signi¢cantly high homologies with microbial acetyl-CoA syn-
thetases, bearing 25.0% and 38.9% homologies with acetyl-
CoA synthetases of Saccharomyces cerevisiae [17] (Accession
No. X66425) and Archaeoglobus fulgidus [18] (Accession No.
AE001092), respectively (Fig. 3). When similar amino acids
are considered (I = L, V; F = Y, W; K = R, H; D = E), the
homologies (similarities) were 34.9 and 50.0%, respectively.
It also showed 39.0% homology with Caenorhabditis elegans
clones (Accession No. U41625), which are supposed to be
acetyl-CoA synthetase of C. elegans [19]. Compared to bacte-
rial acetyl-CoA synthetase, any long chain or medium chain
fatty acyl-CoA synthetase, which has been submitted to the
protein sequence database, showed less homology with rat
liver acetoacetyl-CoA synthetase (data not shown).
Amino acid sequences of rat AA-CoA synthetase and ace-
tyl-CoA synthetases of S. cerevisiae and A. fulgidus have
AMP-binding motifs ([LIVMFY]-x(2)-[STG]-[STAG]-G-[ST]-
[STEI]-[SG]-x[PASLIVM]-[KR]) in the same region (rat AA-
CoA synthetase, I287-K298; S. cerevisiae acetyl-CoA synthe-
tase L317-K328; A. fulgidus acetyl-CoA synthetase V276-
K287). The AMP-binding motif is shown in a number of
prokaryotic and eukaryotic enzymes which all probably act
via an ATP-dependent covalent binding of AMP to their sub-
strate, and share a region of sequence similarity [20^22]. In
Fig. 3, WMMWNWM in rat AA-CoA synthetase (W395-
M341) is also noticed. Methionine and tryptophan are rarely
distributed amino acids in common protein sequence [23], so
this region might play an important role for catalysis or its
protein structure. Regulation of the AA-CoA synthetase ex-
pression under the various physiological conditions is under
investigation using cDNA encoding this enzyme.
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Fig. 3. Homology alignments of AA-CoA synthetase of rat and acetyl-CoA synthetases of S. cerevisiae (indicated as Sc) and A. fulgidus (indi-
cated as Af). Boxes indicate identical amino acid residues of the sequences.
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